IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NVP Associates, LLC

Q2 2026 Holdings

Filed 2026-08-07 | 7 holdings | $328.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
MBX Biosciences Inc(MBX)COM55287L101$117.9M2,136,33535.9%
Avalyn Pharmaceuticals Inc(AVLN)COM SHS05348Y105$74.7M2,268,40422.8%
Omada Health Inc(OMDA)COM68170A108$55.6M2,531,00016.9%
Zenas Biopharma Inc(ZBIO)COM98937L105$46.7M1,838,48214.2%
Snowflake Inc(SNOW)COM SHS833445109$29.2M114,7868.9%
Grove Collaborative Hold Inc(GROV)COM CL A39957D201$4.0M3,225,0971.2%
Ondas Inc(ONDS)COM NEW68236H204$128.6K15,6020.0%